4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000081
President and CEO sold 4,806 shares at $4.38 ($21,041)
- President and CEO acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 1 in the form | +10,938 | 227,764 | D | ||
| 2021-06-02 | Sale : show line 2 in the form | −4,806 | $4.38 | $21,041 | 222,958 | D |
| Open-market sales · 4,806 sh · avg $4.38 · $21,041 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,938 | 65,625 | D |
Loading xslF345X03/wf-form4_162275218310282.xml…